Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta

被引:58
作者
Hussain, MB
Hobbs, AJ
MacAllister, RJ
机构
[1] Univ London Univ Coll, Rayne Inst, Wolfson Inst Biomed Res, London WC1E 6JJ, England
[2] Univ London Univ Coll, Rayne Inst, Ctr Clin Pharmacol, London WC1E 6JJ, England
基金
英国惠康基金;
关键词
eNOS knockout mice; nitric oxide; YC-1; soluble guanylate cyclase; feedback regulation; cyclic GMP;
D O I
10.1038/sj.bjp.0702874
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The sensitivity of the soluble guanylate cyclase (sGC)-cyclic guanosine-3',5'-monophosphate (cyclic GMP) system to nitric oxide (NO was investigated in mouse aorta from wild type (WT) and NO synthase (NOS) knockout (KO) animals. 2 The NO donor, spermine-NONOate (SPER-NO) was more potent in aortas from eNOS KO mice compared to WT (pEC(50) 7.30 +/- 0.06 and 6.56 +/- 0.04, respectively; n = 6; P < 0.05). In contrast, the non-NO based sGC activator, YC-1 was equipotent in vessels from eNOS WT and KO mice. The sensitivity of aortas from nNOS and iNOS KO animals to SPER-NO was unchanged. Forskolin tan adenylate cyclase activator), was equipotent in vessels from eNOS WT and KO animals. 3 The cyclic GMP analogue, 8-Br-cGMP was equipotent in eNOS WT and KO mice (pEC(50) 4.38 +/- 0.04 and 4.40 +/- 0.05, respectively; n = 5; P > 0.05). Zaprinast (10(-5) M) a phosphodiesterase type V (PDE V) inhibitor, had no effect on the response to SPER-NO in vessels from eNOS WT or KO mice. 4 The NOS inhibitor N-G-nitro-L-arginine methyl ester (r-NAME; 3 x 10(-4) M) increased the potency of SPER-NO in aortas from WT mice (pEC(50) 6.64 +/- 0.02 and 7.37 +/- 0.02 in the absence and presence of L-NAME, respectively; n = 4; P < 0.05. 5 In summary, there is increased sensitivity of vessels from eNOS KO animals to NO. Cyclic AMP-mediated dilatation is unchanged, consistent with a specific up-regulation of sGC-cyclic GMP signalling. The functional activity of cyclic GMP-dependent protein kinase (G-kinase) and PDE V was also unchanged, suggesting that sGC is the site of up-regulation. These alterations in the sensitivity of the sGC-cyclic GMP pathway might represent a mechanism for the dynamic regulation of NO bioactivity.
引用
收藏
页码:1082 / 1088
页数:7
相关论文
共 30 条
[21]   CHARACTERIZATION OF 3 INHIBITORS OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE INVITRO AND INVIVO [J].
REES, DD ;
PALMER, RMJ ;
SCHULZ, R ;
HODSON, HF ;
MONCADA, S .
BRITISH JOURNAL OF PHARMACOLOGY, 1990, 101 (03) :746-752
[22]   Sustained nitric oxide exposure decreases soluble guanylate cyclase mRNA and enzyme activity in pulmonary artery smooth muscle [J].
Scott, WS ;
Nakayama, DK .
JOURNAL OF SURGICAL RESEARCH, 1998, 79 (01) :66-70
[23]   Smooth muscle cell expression of type I cyclic GMP-dependent protein kinase is suppressed by continuous exposure to nitrovasodilators, theophylline, cyclic GMP, and cyclic AMP [J].
Soff, GA ;
Cornwell, TL ;
Cundiff, DL ;
Gately, S ;
Lincoln, TM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (10) :2580-2587
[24]   THE CGMP PHOSPHODIESTERASE INHIBITOR ZAPRINAST ENHANCES THE EFFECT OF NITRIC-OXIDE [J].
THUSU, KG ;
MORIN, FC ;
RUSSELL, JA ;
STEINHORN, RH .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (05) :1605-1610
[25]  
Vallance P, 1993, New Horiz, V1, P77
[26]  
van der Zypp A, 1998, CLIN EXP PHARMACOL P, V25, P38
[27]  
WALDMAN SA, 1987, PHARMACOL REV, V39, P163
[28]   Caution with use of inhaled nitric oxide [J].
Warren, JB ;
Higenbottam, T .
LANCET, 1996, 348 (9028) :629-630
[29]   Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide [J].
Weisbrod, RM ;
Griswold, MC ;
Yaghoubi, M ;
Komalavilas, P ;
Lincoln, TM ;
Cohen, RA .
BRITISH JOURNAL OF PHARMACOLOGY, 1998, 125 (08) :1695-1707
[30]   Cyclic GMP regulates cromakalim-induced relaxation in the rat aortic smooth muscle:: Role of cyclic GMP in KATP-channels [J].
Wu, CC ;
Chen, SJ ;
Yen, MH .
LIFE SCIENCES, 1999, 64 (26) :2471-2478